212 related articles for article (PubMed ID: 27669292)
1. YAP Inhibition by Resveratrol via Activation of AMPK Enhances the Sensitivity of Pancreatic Cancer Cells to Gemcitabine.
Jiang Z; Chen X; Chen K; Sun L; Gao L; Zhou C; Lei M; Duan W; Wang Z; Ma Q; Ma J
Nutrients; 2016 Sep; 8(10):. PubMed ID: 27669292
[TBL] [Abstract][Full Text] [Related]
2. Catechol enhances chemo‑ and radio‑sensitivity by targeting AMPK/Hippo signaling in pancreatic cancer cells.
Moon JY; Ediriweera MK; Ryu JY; Kim HY; Cho SK
Oncol Rep; 2021 Mar; 45(3):1133-1141. PubMed ID: 33650657
[TBL] [Abstract][Full Text] [Related]
3. YAP Inhibition by Nuciferine via AMPK-Mediated Downregulation of HMGCR Sensitizes Pancreatic Cancer Cells to Gemcitabine.
Zhou L; Wang Q; Zhang H; Li Y; Xie S; Xu M
Biomolecules; 2019 Oct; 9(10):. PubMed ID: 31627466
[TBL] [Abstract][Full Text] [Related]
4. YAP overexpression promotes the epithelial-mesenchymal transition and chemoresistance in pancreatic cancer cells.
Yuan Y; Li D; Li H; Wang L; Tian G; Dong Y
Mol Med Rep; 2016 Jan; 13(1):237-42. PubMed ID: 26572166
[TBL] [Abstract][Full Text] [Related]
5. A combinatorial strategy using YAP and pan-RAF inhibitors for treating KRAS-mutant pancreatic cancer.
Zhao X; Wang X; Fang L; Lan C; Zheng X; Wang Y; Zhang Y; Han X; Liu S; Cheng K; Zhao Y; Shi J; Guo J; Hao J; Ren H; Nie G
Cancer Lett; 2017 Aug; 402():61-70. PubMed ID: 28576749
[TBL] [Abstract][Full Text] [Related]
6. Resveratrol-Induced Downregulation of NAF-1 Enhances the Sensitivity of Pancreatic Cancer Cells to Gemcitabine via the ROS/Nrf2 Signaling Pathways.
Cheng L; Yan B; Chen K; Jiang Z; Zhou C; Cao J; Qian W; Li J; Sun L; Ma J; Ma Q; Sha H
Oxid Med Cell Longev; 2018; 2018():9482018. PubMed ID: 29765509
[TBL] [Abstract][Full Text] [Related]
7. Desmoplasia suppression by metformin-mediated AMPK activation inhibits pancreatic cancer progression.
Duan W; Chen K; Jiang Z; Chen X; Sun L; Li J; Lei J; Xu Q; Ma J; Li X; Han L; Wang Z; Wu Z; Wang F; Wu E; Ma Q; Ma Z
Cancer Lett; 2017 Jan; 385():225-233. PubMed ID: 27773749
[TBL] [Abstract][Full Text] [Related]
8. Bmi1 inhibition enhances the sensitivity of pancreatic cancer cells to gemcitabine.
Yin T; Zhang Z; Cao B; Duan Q; Shi P; Zhao H; Camara SN; Shen Q; Wang C
Oncotarget; 2016 Jun; 7(24):37192-37204. PubMed ID: 27177084
[TBL] [Abstract][Full Text] [Related]
9. Cellular energy stress induces AMPK-mediated regulation of YAP and the Hippo pathway.
Mo JS; Meng Z; Kim YC; Park HW; Hansen CG; Kim S; Lim DS; Guan KL
Nat Cell Biol; 2015 Apr; 17(4):500-10. PubMed ID: 25751140
[TBL] [Abstract][Full Text] [Related]
10. Resveratrol suppresses breast cancer cell invasion by inactivating a RhoA/YAP signaling axis.
Kim YN; Choe SR; Cho KH; Cho DY; Kang J; Park CG; Lee HY
Exp Mol Med; 2017 Feb; 49(2):e296. PubMed ID: 28232662
[TBL] [Abstract][Full Text] [Related]
11. Resveratrol enhances the chemotherapeutic response and reverses the stemness induced by gemcitabine in pancreatic cancer cells via targeting SREBP1.
Zhou C; Qian W; Ma J; Cheng L; Jiang Z; Yan B; Li J; Duan W; Sun L; Cao J; Wang F; Wu E; Wu Z; Ma Q; Li X
Cell Prolif; 2019 Jan; 52(1):e12514. PubMed ID: 30341797
[TBL] [Abstract][Full Text] [Related]
12. Resveratrol and capsaicin used together as food complements reduce tumor growth and rescue full efficiency of low dose gemcitabine in a pancreatic cancer model.
Vendrely V; Peuchant E; Buscail E; Moranvillier I; Rousseau B; Bedel A; Brillac A; de Verneuil H; Moreau-Gaudry F; Dabernat S
Cancer Lett; 2017 Apr; 390():91-102. PubMed ID: 28089829
[TBL] [Abstract][Full Text] [Related]
13. Pak2 inhibition promotes resveratrol-mediated glioblastoma A172 cell apoptosis via modulating the AMPK-YAP signaling pathway.
Xing J; Wang Z; Xu H; Liu C; Wei Z; Zhao L; Ren L
J Cell Physiol; 2020 Oct; 235(10):6563-6573. PubMed ID: 32017068
[TBL] [Abstract][Full Text] [Related]
14. Fendiline Enhances the Cytotoxic Effects of Therapeutic Agents on PDAC Cells by Inhibiting Tumor-Promoting Signaling Events: A Potential Strategy to Combat PDAC.
Alhothali M; Mathew M; Iyer G; Lawrence HR; Yang S; Chellappan S; Padmanabhan J
Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31100813
[TBL] [Abstract][Full Text] [Related]
15. Implication of 4E-BP1 protein dephosphorylation and accumulation in pancreatic cancer cell death induced by combined gemcitabine and TRAIL.
Elia A; Henry-Grant R; Adiseshiah C; Marboeuf C; Buckley RJ; Clemens MJ; Mudan S; Pyronnet S
Cell Death Dis; 2017 Dec; 8(12):3204. PubMed ID: 29233971
[TBL] [Abstract][Full Text] [Related]
16. The enhancement of Tetrandrine to gemcitabine-resistant PANC-1 cytochemical sensitivity involves the promotion of PI3K/Akt/mTOR-mediated apoptosis and AMPK-regulated autophagy.
Song J; Xu J; Guo J; Shang Y; Wang J; Wang T
Acta Histochem; 2021 Sep; 123(6):151769. PubMed ID: 34416437
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-1285 inhibits malignant biological behaviors of human pancreatic cancer cells by negative regulation of YAP1.
Huang H; Xiong G; Shen P; Cao Z; Zheng L; Zhang T; Zhao Y
Neoplasma; 2017; 64(3):358-366. PubMed ID: 28253715
[TBL] [Abstract][Full Text] [Related]
18. Platelet‑derived growth factor‑BB mediates pancreatic cancer malignancy via regulation of the Hippo/Yes‑associated protein signaling pathway.
Li T; Guo T; Liu H; Jiang H; Wang Y
Oncol Rep; 2021 Jan; 45(1):83-94. PubMed ID: 33416116
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of AKT2 enhances sensitivity to gemcitabine via regulating PUMA and NF-κB signaling pathway in human pancreatic ductal adenocarcinoma.
Chen D; Niu M; Jiao X; Zhang K; Liang J; Zhang D
Int J Mol Sci; 2012; 13(1):1186-1208. PubMed ID: 22312312
[TBL] [Abstract][Full Text] [Related]
20. 14-3-3σ regulation of and interaction with YAP1 in acquired gemcitabine resistance via promoting ribonucleotide reductase expression.
Qin L; Dong Z; Zhang JT
Oncotarget; 2016 Apr; 7(14):17726-36. PubMed ID: 26894857
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
